My big takeon this interview was at the 6 min mark – slide number 3, Simon spoke about theLab on a Chip and the higher revenue this could bring to the major pharmaceuticalcompanies. Doctor can not monitor the levels of abnormal potassium (ChronicKidney Disease) as often as they need (they generally perform tests monthly,which is to slow and not frequently enough as well as costly) if this was donemore regularly (using our Lab on a Chip devise) then more as well as thecorrect levels of medication can be subscribed, vastly increasing the levels ofmedication sold (of which these pharmaceutical companies have alreadydeveloped).
And anysuch collaboration with one of these companies would lend itself to Archer gettinghelp/assistance in getting FDA approval.
When and notif, we get a collaboration announcement, we would see a massive re-rating ofthe share price.
My big takeon this interview was at the 6 min mark – slide...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $71.35M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 28.0¢ | $32.59K | 114.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17601 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 58500 | 2 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| AXE (ASX) Chart |